df-mp - Patent Law Firm of the Year 2011 in Germany
We are honored to announce that df-mp has won two independent awards in the category Patents - Law Firm of the Year 2011 in Germany.
 |
 |
Patents - German Law
Firm of the Year
2011 |
2011 German - Patents
Law Firm of the
Year |
df-mp - Global Expertise for Your Innovations and Trademarks
df-mp is one of the top firms in intellectual property law with an international outlook and a broad scope of specialized expertise. Globally-oriented companies in such practice areas as biotechnology, chemistry, physics, medical devices, mechanical and electrical engineering and pharmaceuticals trust the competent advice offered by our highly-rated team.
df-mp is located in Munich in the vicinity of the European Patent Office, the German Patent- and Trademark Office and the German Federal Patents Court, affording direct access to these institutions.
df-mp - Dual Qualifications in Europe and the U.S.
The patent attorneys of df-mp focus on proceedings in Germany and Europe, as well as the U.S. We are thus in the unique position to be able to develop comprehensive intellectual property protection strategies for your company that account for the different legal requirements in Europe and the U.S.
df-mp - Global IP Strategies
df-mp has developed and cultivates a worldwide network of specialists who closely collaborate with df-mp during planning and implementation of the global IP strategy of your company.
df-mp - Career Opportunities
df-mp is continuously growing. Here you can find our current job offers.
back to the top
DEUTSCH |
ENGLISH
ContactDisclaimer
df-mp - News
IAM magazine names df-mp as one of 10 recommended firms for patent nullity actions in Germany – Dr. H. Ulrich Dörries listed as "recommended expert"
In the 2011 edition of "IAM Patent Litigation 250 – The World’s Leading Patent Litigators", Intellectual Asset Management (IAM) magazine names df-mp amongst the 10 recommended law firms for patent nullity actions in Germany.read more
df-mp - IP News
A Blow to Broad Medical Use Claims from Technical Board 3.3.10?
In a recent decision (T 1063/06) Technical Board of Appeal 3.3.10 ruled that a Swiss-type claim relating to the use of a "functionally" defined compound (stimulator)is to be considered as a "reach-through" claim that does not fulfill the requirements of Article 83 EPC (sufficiency of disclosure).read more
The practice of filing European divisional applications will fundamentally change as of 1 April 2010
As of 1 April 2010 the EPO will change its practice in filing divisional applications which will have a major influence on prosecution strategy and management of patent portfolios read more
German Federal Supreme Court Refines Novelty Test in Chemical Cases in Lilly's "Olanzapine" Case
The Federal Supreme Court (FSC) had recently decided to annul the German Federal Patent Court's earlier decision to revoke the German part of Eli Lilly's European patent EP 454 436-B1 to Olanzapine (Zyprexa®) in a hearing held on December 16, 2008. The eagerly awaited written decision is now available read more
Bill for the Modernisation of German Patent Law
On October 15, 2008 a bill was agreed upon by the Federal Government to simplify and modernise patent law in Germany. The new law is yet to be ratified by the German Parliament ("Bundestag"). The aim of the changes to the law is to simplify the filing of patents and trademarks and to shorten court proceedings, particularly in patent nullity proceedings. read more
EPO Enlarged Board of Appeal renders decision in G 2/06 "WARF/Thomson stem cell application"
The Enlarged Board of Appeal (EBoA) of the EPO has made a ruling in an appeal connected to the so-called WARF/Thomson stem cell application. The ruling contains clarifications to questions posed by a Technical Board of Appeal dealing with the patentability of the WARF application. read more
Contact
df-mp
Fünf Höfe
Theatinerstraße 16
80333 Munich
Phone: + 49 89 210 296 0
Fax:+ 49 89 210 296 33
info@df-mp.com
